These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25703419)

  • 121. Temporal trends in treatment strategies and clinical outcomes among patients with advanced chronic kidney disease and ST-elevation myocardial infarctions: results from the Bremen STEMI registry.
    Schmucker J; Fach A; Osteresch R; Mata Marin LA; Retzlaff T; Rühle S; Garstka D; Kuhlmann U; Eitel I; Hambrecht R; Wienbergen H
    BMC Cardiovasc Disord; 2022 Apr; 22(1):142. PubMed ID: 35365074
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Ticagrelor and the risk of infections during hospitalization in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
    Lian XJ; Dai YN; Xue JH; Zeng LH; Wang LT; Xue L; Chen JY; Tan N; He PC; Liu YH; Duan CY
    Atherosclerosis; 2021 Aug; 331():6-11. PubMed ID: 34252837
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Summary of the European Society of Cardiology guidelines on dual antiplatelet therapy in patients after percutaneous coronary interventions.
    Hudzik B; Błachut A; Lesiak M; Kubica J; Wojakowski W; Gąsior M
    Kardiol Pol; 2022; 80(10):974-989. PubMed ID: 36036339
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Antiplatelet Therapy in Acute Myocardial Infarction and Cardiogenic Shock: Insights From the National Cardiogenic Shock Initiative.
    Gorgis S; Lemor A; Kolski B; Lalonde T; Kaki A; Marso S; Senter S; Rahman A; Gorwara S; Nazir R; Zuberi O; Justice L; Srivastava N; Padgett R; O'Neill W; Basir MB
    J Invasive Cardiol; 2022 Mar; 34(3):E156-E163. PubMed ID: 35157607
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Guideline-adherent therapy in patients with acute coronary syndromes. The EPICOR registry in Germany.
    Zeymer U; Heuer H; Schwimmbeck P; Genth-Zotz S; Wolff K; Nienaber CA;
    Herz; 2015 Mar; 40 Suppl 1():27-35. PubMed ID: 25374386
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Effectiveness and Safety of P2Y12 Inhibitors Pretreatment in Primary Percutaneous Coronary Intervention with Long Transfer Times.
    Roule V; Rebouh I; Roupie E; Malcor G; Bignon M; Trotel J; Potier B; Lecoq G; Arrot X; Beygui F
    J Emerg Med; 2022 Feb; 62(2):240-249. PubMed ID: 34955318
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trial.
    Vogel RF; Delewi R; Wilschut JM; Lemmert ME; Diletti R; van Vliet R; van der Waarden NWPL; Nuis RJ; Paradies V; Alexopoulos D; Zijlstra F; Montalescot G; Angiolillo DJ; Krucoff MW; Smits PC; Van Mieghem NM; Vlachojannis GJ
    Am Heart J; 2022 Oct; 252():26-30. PubMed ID: 35671829
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI.
    Ki YJ; Lee BK; Park KW; Bae JW; Hwang D; Kang J; Han JK; Yang HM; Kang HJ; Koo BK; Kim DB; Chae IH; Moon KW; Park HW; Won KB; Jeon DW; Han KR; Choi SW; Ryu JK; Jeong MH; Cha KS; Kim HS;
    Korean Circ J; 2022 Apr; 52(4):304-319. PubMed ID: 35129316
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Replay to "duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk".
    Fujii T
    Int J Cardiol; 2023 Jun; 381():1. PubMed ID: 36933664
    [No Abstract]   [Full Text] [Related]  

  • 130. Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunction.
    Uemura Y; Ishikawa S; Takemoto K; Negishi Y; Tanaka A; Takagi K; Yoshioka N; Umemoto N; Inoue Y; Morishima I; Shibata N; Asano H; Ishii H; Watarai M; Murohara T;
    Clin Exp Nephrol; 2020 Apr; 24(4):339-348. PubMed ID: 31903510
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial.
    Kitazono T; Toyoda K; Kitagawa K; Nagao T; Yamagami H; Uchiyama S; Tanahashi N; Matsumoto M; Minematsu K; Nagata I; Nishikawa M; Nanto S; Ikeda Y; Shirai T; Abe K; Ogawa A;
    J Atheroscler Thromb; 2021 Feb; 28(2):169-180. PubMed ID: 32493881
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Women were noninferior to men in cardiovascular outcomes among patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention from Taiwan acute coronary syndrome full-spectrum registry.
    Chou LP; Zhao P; Kao C; Chen YH; Jong GP
    Medicine (Baltimore); 2018 Oct; 97(43):e12998. PubMed ID: 30412135
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice.
    Bauer T; Hoffmann R; Jünger C; Koeth O; Zahn R; Gitt A; Heer T; Bestehorn K; Senges J; Zeymer U
    Clin Res Cardiol; 2009 Mar; 98(3):171-8. PubMed ID: 19030907
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Impact of preprocedural coronary flow grade on duration of dual antiplatelet therapy in acute myocardial infarction.
    Kim YH; Her AY; Kim BK; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Sci Rep; 2021 Jun; 11(1):11735. PubMed ID: 34083627
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Dual Antiplatelet Therapy Following PCI for NSTEMI: An Obvious Choice or a Calculated Decision?
    Korjian S; Dangas G; Gibson CM
    J Am Coll Cardiol; 2020 Nov; 76(21):2447-2449. PubMed ID: 33213723
    [No Abstract]   [Full Text] [Related]  

  • 136. Therapeutic Effects of Triple Antiplatelet Therapy in Elderly Female Patients with Diabetes and Acute Myocardial Infarction.
    Liu Y; Gao Y; Liu H; Chen Q; Ji J; Jia K
    Arq Bras Cardiol; 2021 Feb; 116(2):229-235. PubMed ID: 33470329
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Relation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: from the National Cardiovascular Data Registry.
    Mogabgab O; Wiviott SD; Antman EM; Foody JM; Wang TY; Sabatine MS; Cannon CP; Li S; Giugliano RP
    Clin Cardiol; 2013 Apr; 36(4):222-7. PubMed ID: 23520015
    [TBL] [Abstract][Full Text] [Related]  

  • 138. P2Y
    Moura Guedes JP; Marques N; Azevedo P; Mota T; Bispo J; Fernandes R; Costa H; Vinhas H; Mimoso J; de Jesus I
    Rev Port Cardiol (Engl Ed); 2020 Oct; 39(10):553-561. PubMed ID: 33023777
    [TBL] [Abstract][Full Text] [Related]  

  • 139. [Management of acute myocardial infarction with ST-segment elevation: Update 2013].
    Birkmeier S; Thiele H; Dörr R
    Herz; 2013 Dec; 38(8):889-98; quiz 899. PubMed ID: 24068024
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry.
    Rivera-Caravaca JM; Ruiz-Nodar JM; Tello-Montoliu A; Esteve-Pastor MA; Veliz-Martínez A; Orenes-Piñero E; Valdés M; Pernias-Escrig V; Sandin-Rollán M; Vicente-Ibarra N; Macías-Villanego MJ; Candela-Sánchez E; Lozano T; Carrillo-Alemán L; Marín F
    Eur J Cardiovasc Nurs; 2017 Dec; 16(8):696-703. PubMed ID: 28509568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.